http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Experimental and Clinical Study of Korea Red Ginseng Treatment on Hypertension
(En Yuan Jin),(Ming Jin),(Yu Lin Wei),(Lin Hun Huang),(Xiao Ping Yan),(Zai Xiang Shi),(Li Huang),(De Chu Shen),(Ren Jie Fu),(Tian Yu Zhao),(Ki Yeul Kam),(Akira Kumagai) 고려인삼학회 1998 Advances in Ginseng Research - Proceedings of the Vol.- No.-
The genome of the cucumber, Cucumis sativus L.
Huang, Sanwen,Li, Ruiqiang,Zhang, Zhonghua,Li, Li,Gu, Xingfang,Fan, Wei,Lucas, William J,Wang, Xiaowu,Xie, Bingyan,Ni, Peixiang,Ren, Yuanyuan,Zhu, Hongmei,Li, Jun,Lin, Kui,Jin, Weiwei,Fei, Zhangjun,Li Nature Publishing Group 2009 Nature genetics Vol.41 No.12
Cucumber is an economically important crop as well as a model system for sex determination studies and plant vascular biology. Here we report the draft genome sequence of Cucumis sativus var. sativus L., assembled using a novel combination of traditional Sanger and next-generation Illumina GA sequencing technologies to obtain 72.2-fold genome coverage. The absence of recent whole-genome duplication, along with the presence of few tandem duplications, explains the small number of genes in the cucumber. Our study establishes that five of the cucumber's seven chromosomes arose from fusions of ten ancestral chromosomes after divergence from Cucumis melo. The sequenced cucumber genome affords insight into traits such as its sex expression, disease resistance, biosynthesis of cucurbitacin and 'fresh green' odor. We also identify 686 gene clusters related to phloem function. The cucumber genome provides a valuable resource for developing elite cultivars and for studying the evolution and function of the plant vascular system.
Huang, Xin-En,Tian, Guang-Yu,Cao, Jie,Xu, Xia,Lu, Yan-Yan,Wu, Xue-Yan,Liu, Jin,Shi, Lin,Xiang, Jin Asian Pacific Journal of Cancer Prevention 2013 Asian Pacific journal of cancer prevention Vol.14 No.11
Purpose: The current research was conducted to investigate the efficacy and safety of pemetrexed given continuously as a basement agent for first-, second- to third line chemotherapy of patients with metastatic lung adenocarcinoma. Patients and Methods: Patients with metastatic lung adenocarcinoma who were diagnosed in Jiangsu Cancer Hospital and Research Insitute, were enrolled. All received pemetrexed 500 $mg/m^2$ (intravenous; on day 1), and another chemotherapieutic agent every 3 weeks until disease progression, or intolerable toxicity. Then the patients were changed to a second line chemotherapy that was still based on pemetrexed 500 $mg/m^2$ and another chemotherapeutic agent differing from the first line example, until disease progression, or intolerable toxicity. When third line chemotherapy was needed, pemetrexed 500 $mg/m^2$ and another new chemotherapeutic agent were combined until disease progression. Evaluation of efficacy was conducted after two cycles of chemotherapy using the Response Evaluation Criteria for Solid Tumors. Toxicity was recorded according to NCI Criteria for Adverse Events version 3.0. Results: From January 2010 to September 2013, 15 patients were enrolled. Their median age was 56 years (range 43 to 77 years). Eight patients were male and 7 female. Five patients (33.3%) achieved PR, while 6 patients (40.0%) remained stable, no CR on first line; and 1 PR (7.7%), 5 stable (38.5%) were recorded when pemetrexed was ordered in second line; 5 patients (41.7%) were stable after pemetrexed was combined in third line; no complete response was observed. Main side effects were grade 1 to 2 neutrophil suppression and thrombocytopenia. Other toxicities included elevated transaminase and oral mucositis, but no treatment related death occurred. Conclusions: Pemetrexed continuously as a basement agent from first-, second- to third line chemotherapy is mildly effective in treating patients with metastatic lung adenocarcinoma with tolerable toxicity.
Leucogen Tablets at 60 mg Three Times per Day are Safe and Effective to Control Febrile Neutropenia
Huang, Xin-En,Cao, Jie,Qian, Zhi-Ying,Xu, Xia,Shi, Lin,Wu, Xue-Yan,Liu, Jin,Wang, Lin Asian Pacific Journal of Cancer Prevention 2014 Asian Pacific journal of cancer prevention Vol.15 No.19
Purpose: To investigate whether it is safe to use leucogen tablets 60 mg three times per day (180 mg for a day) and whether this regimen could reduce the incidence of febrile neutropenia caused by chemotherapy. Methods: This prospectively designed study focused on the safety and effectiveness of leucogen tablets 60mg three times per day for a group of cancer patients during chemotherapy for mainly lung or gastric cancers. The tablets were administered from 5 days before until the termination of chemotherapy. Neutropenia and other healthcare encounters were defined as events and occurrence was estimated for comparison. Results: We identified 39 patients receiving leucogen tablets 60mg three times per day, including 11 with gastric, 12 with lung and 16 with other sites of cancer. The mean age was 65 (29-75) years and there were 27 male and 12 female patients. The mean duration of leucogen tablets intake was 59 days. Eighteen patients were treated with taxane-based, 4 with irinotecan-based and 17 with other chemotherapy. The incidence of febrile neutropenia was 0%. Twelve patients were found severe neutropenia (grade III/IV), and the duration of severe neutropenia (grade III/IV) was 5 days. Treatment-emergent adverse events were attributable to complications of myelosuppressive chemotherapy or the primary disease (i.e., alopecia, nausea, asthenia, neutropenia, and severe hepatic renal dysfunction). No chemotherapy was delayed and no treatment related death was observed. Conclusions: This study suggested that leucogen tablets 60mg three times per day (180mg for a day) are safe and could be effective for preventing febrile neutropenia in patients with chemotherapy.
Huang Liang,Bai Fenghua,Zhang Yutian,Zhang Shanshan,Jin Tianbo,Wei Xingwei,Zhou Xiaoli,Lin Mei,Xie Yufei,He Chanyi,Lin Qi,Xie Tian,Ding Yipeng 한국유전학회 2022 Genes & Genomics Vol.44 No.8
Background: Thyroid hormones are critical regulators of metabolism, development and growth in mammals. However, the genetic association of thyroid-related hormones in the Chinese Han population is not fully understood. Objective: We aimed to identify the genetic loci associated with circulating thyroid-related hormones concentrations in the healthy Chinese Han population. Methods: Genotyping was performed in 124 individuals using Applied Biosystems™ Axiom™ PMDA, and 796,288 single nucleotide polymorphisms (SNPs) were available for the GWAS analysis. For replication, eleven SNPs were selected as candidate loci for genotyping by Agena MassARRAY platform in additional samples (313 subjects). The values of p < 5 × 10- 6 suggest a suggestively significant genome-wide association with circulating thyroid-related hormones concentrations. Results: We identified that rs11178277 (PTPRB, p = 4.88 × 10- 07) and rs7320337 (LMO7DN-KCTD12, p = 1.22 × 10- 06) were associated with serum FT3 level. Three SNPs (rs4850041 in LOC105373394-LINC01249: p = 3.55 × 10- 06, rs6867291 in LINC02208: p = 2.40 × 10- 06 and rs79508321 in WWOX: p = 3.35 × 10- 06) were related to circulating T3 level. Rs12474167 (LOC105373394-LINC01249, p = 1.65 × 10- 06) and rs1864553 (IWS1, p = 2.00 × 10- 06) were associated with circulating T4 concentration. The association with TGA concentration was for rs17163542 in DISP1 (p = 3.46 × 10- 06) and rs12601151 in NOG-C17orf67 (p = 2.72 × 10- 07). Two genome-level significant SNPs (rs2114707 in LINC01314, p = 1.69 × 10- 06 and rs12601151, p = 1.41 × 10- 07) associated with serum TMA concentration were identified. Moreover, rs6083269 (CST1-CST2, p = 3.36 × 10- 06) was a significant locus for circulating TSH level. In replication, rs12601151 in NOG-C17orf67 was still associated with serum TGA level (p = 0.012). Conclusions: The GWAS reported 11 new suggestively significant loci associated with circulating thyroid-related hormones levels among the Chinese Han population. These findings represented suggestively biological candidates for circulating thyroid-related hormones levels and provided new insights into the mechanisms of regulating serum TGA concentration.
APMP.QM-K111-propane in nitrogen
Lin, Tsai-Yin,Liu, Hsin-Wang,Huang, Chiung-Kun,Kang, Namgoo,Bae, Hyun Kil,Woo, Jin Chun,Bi, Zhe,Zhou, Zeyi,Sinweeruthai, Ratirat,Wongjuk, Arnuttachai,Li, Hou,Keat, Teo Beng,Hui, Liu,Wu, Thomas,Ann, Ch BUREAU INTERNATIONAL DES POIDS ET MESURES 2018 METROLOGIA -BERLIN- Vol.55 No.1
Qin, Lin,Cai, Peiqing,Chen, Cuili,Wang, Jing,Kim, Sun Il,Huang, Yanlin,Seo, Hyo Jin Elsevier 2018 JOURNAL OF ALLOYS AND COMPOUNDS Vol.738 No.-
<P><B>Abstract</B></P> <P>Ba<SUB>5</SUB>Al<SUB>3</SUB>F<SUB>19</SUB>:Eu<SUP>2+</SUP> blue-emitting phosphors were synthesized by the solid state reaction in a reductive atmosphere. The crystal structure of Ba<SUB>5</SUB>Al<SUB>3</SUB>F<SUB>19</SUB>:Eu<SUP>2+</SUP> phosphors were characterized by using the X-ray powder diffraction (XRD) measurement. The luminescence properties are investigated systematically based on the crystal structure. Emission and excitation spectra of the Ba<SUB>5</SUB>Al<SUB>3</SUB>F<SUB>19</SUB>:Eu<SUP>2+</SUP> phosphor along with the decay curves were characterized. Under the excitation of UV light, the phosphor exhibits a broad band emission around 410 nm ascribed to the allowed 4<I>f</I> <SUP>6</SUP>5<I>d</I>→4<I>f</I> <SUP>7</SUP>(<SUP>8</SUP>S<SUB>7/2</SUB>) transition, together with a sharp line at 360 nm corresponding to the forbidden 4<I>f</I> <SUP>7</SUP>(<SUP>6</SUP>P<SUB>7/2</SUB>)→4<I>f</I> <SUP>7</SUP>(<SUP>8</SUP>S<SUB>7/2</SUB>) transition of the Eu<SUP>2+</SUP> ions. The temperature dependent emission spectra and decay curves were measured to investigate the origins of the emission and the thermal stabilities of the as-prepared phosphors. The as-prepared Ba<SUB>5</SUB>Al<SUB>3</SUB>F<SUB>19</SUB>:Eu<SUP>2+</SUP> phosphors display interesting and stable luminescence properties, which can act as promising blue-emitting phosphor candidates.</P> <P><B>Highlights</B></P> <P> <UL> <LI> We developed Ba<SUB>5</SUB>Al<SUB>3</SUB>F<SUB>19</SUB> fluoride by a simple solid state method. </LI> <LI> The phosphor exhibits a bright broad band emission. </LI> <LI> 4<I>f</I> <SUP>7</SUP>(<SUP>6</SUP>P<SUB>7/2</SUB>)→4<I>f</I> <SUP>7</SUP>(<SUP>8</SUP>S<SUB>7/2</SUB>) transition of the Eu<SUP>2+</SUP> ions can be observed in this system; </LI> <LI> The Ba<SUB>5</SUB>Al<SUB>3</SUB>F<SUB>19</SUB>:Eu<SUP>2+</SUP> phosphor shows excellent thermal stability at high temperature. </LI> </UL> </P>